Cabaletta Bio, Inc.
CABA
$1.59
-$0.03-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.13M | -35.94M | -32.59M | -30.63M | -27.60M |
| Total Depreciation and Amortization | 468.00K | 485.00K | 468.00K | 424.00K | 426.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.17M | 7.70M | 6.12M | 6.98M | 6.42M |
| Change in Net Operating Assets | 4.07M | -3.05M | 2.87M | 2.90M | -31.00K |
| Cash from Operations | -30.43M | -30.80M | -23.12M | -20.32M | -20.79M |
| Capital Expenditure | -161.00K | -785.00K | -376.00K | -253.00K | -770.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.04M | -- | 12.50M | 12.50M | 24.50M |
| Cash from Investing | -49.20M | -785.00K | 12.12M | 12.25M | 23.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.00M | -552.00K | -897.00K | -- | -- |
| Issuance of Common Stock | 96.38M | -- | 5.27M | 71.00K | 379.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 93.37M | -552.00K | 4.37M | 71.00K | 379.00K |
| Foreign Exchange rate Adjustments | 31.00K | 7.00K | -20.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.78M | -32.13M | -6.65M | -8.01M | 3.32M |